- Home
- MODV vs GRCE Comparison
MODV vs GRCE Comparison
Compare MODV & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- GRCE
- Stock Information
- Founded
- MODV 1996
- GRCE 2002
- Country
- MODV United States
- GRCE United States
- Employees
- MODV N/A
- GRCE N/A
- Industry
- MODV Transportation Services
- GRCE
- Sector
- MODV Consumer Discretionary
- GRCE
- Exchange
- MODV Nasdaq
- GRCE NYSE
- Market Cap
- MODV 48.9M
- GRCE 42.1M
- IPO Year
- MODV N/A
- GRCE N/A
- Fundamental
- Price
- MODV $3.32
- GRCE $3.39
- Analyst Decision
- MODV Buy
- GRCE Strong Buy
- Analyst Count
- MODV 4
- GRCE 1
- Target Price
- MODV $9.17
- GRCE $12.00
- AVG Volume (30 Days)
- MODV 1.1M
- GRCE 59.2K
- Earning Date
- MODV 08-06-2025
- GRCE 08-15-2025
- Dividend Yield
- MODV N/A
- GRCE N/A
- EPS Growth
- MODV N/A
- GRCE N/A
- EPS
- MODV N/A
- GRCE N/A
- Revenue
- MODV $2,753,789,000.00
- GRCE N/A
- Revenue This Year
- MODV N/A
- GRCE N/A
- Revenue Next Year
- MODV $4.90
- GRCE N/A
- P/E Ratio
- MODV N/A
- GRCE N/A
- Revenue Growth
- MODV N/A
- GRCE N/A
- 52 Week Low
- MODV $0.87
- GRCE $1.75
- 52 Week High
- MODV $32.82
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- MODV 59.45
- GRCE N/A
- Support Level
- MODV $3.01
- GRCE N/A
- Resistance Level
- MODV $3.74
- GRCE N/A
- Average True Range (ATR)
- MODV 0.43
- GRCE 0.00
- MACD
- MODV -0.01
- GRCE 0.00
- Stochastic Oscillator
- MODV 60.58
- GRCE 0.00
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.